Prexilon
Prexilon
  • Home
  • About Us
  • Vision & Mission
  • Products
  • Contact
  • More
    • Home
    • About Us
    • Vision & Mission
    • Products
    • Contact
  • Home
  • About Us
  • Vision & Mission
  • Products
  • Contact

About Prexilon

Prexilon Private Limited is a DPIIT-recognised deep-tech diagnostics and AI-enabled bioscience company based in Kochi, Kerala, India, with additional recognition under Startup India, Startup Kerala, and MSME. We are focused on building advanced molecular point-of-care diagnostic platforms and AI-powered screening solutions designed for scalable, real-world healthcare deployment.

Prexilon combines strong scientific and technical capability with deep commercial understanding of the healthcare market in India. Our multidisciplinary ecosystem spans molecular diagnostics, assay development, translational biosciences, AI integration, product strategy, regulatory alignment, and commercialization readiness enabling us to build solutions that are not only innovative, but also practical, scalable, and partnership-ready.

Supported by collaborations with reputed academic institutions including IIIT and engagement with broader clinical and research networks, Prexilon is positioned as a high-potential Indian innovation company for strategic investment, collaboration, technology partnerships, and long-term value creation.

Founder Team

Founder & CEO

Founder & CEO

Founder & CEO

Sinto Antony

MSc Biotechnology  |  MBA


Brings 14+ years of leadership experience across leading multinational pharmaceutical and medical device companies, with commercial exposure spanning cardiovascular care, diabetes, and ostomy care. His strengths include strategic business development, market access, institutional partnerships, distribu

Sinto Antony

MSc Biotechnology  |  MBA


Brings 14+ years of leadership experience across leading multinational pharmaceutical and medical device companies, with commercial exposure spanning cardiovascular care, diabetes, and ostomy care. His strengths include strategic business development, market access, institutional partnerships, distribution strategy, and navigating the Indian healthcare landscape. He combines deep healthcare industry experience with entrepreneurial vision and ecosystem connectivity.


Director

Founder & CEO

Founder & CEO

Aswathy Agnes Joseph

MSc Microbiology  |  PhD Candidate (Biochemistry)


Leads scientific coordination, research execution, and validation alignment across Prexilon’s innovation program's. She ensures scientific integrity, translational relevance, and structured development of diagnostic initiatives through close alignment with research and institutional collaborations.


World Class Technical Team & Scientific Advisory Board

Our broader scientific and advisory ecosystem reflects the multidisciplinary depth required to build globally relevant healthcare innovation. 


Prexilon collaborates with highly qualified experts holding doctoral and postdoctoral credentials from reputed institutions across India, Germany, Japan, and the United States — along with scientific leadership exposure in multinational research and healthcare environments.


•  Doctoral & Postdoctoral Expertise: PhD and postdoctoral specialisation across diagnostics, cancer biology, molecular biosciences, biochemistry, and AI-enabled health technologies.

•  Senior Scientific Leadership: Exposure to principal scientist, director-level, and advanced technical leadership roles in global research and industry settings.

•  International Research Footprint: Academic and scientific experience spanning India, Germany, USA, and Japan.

•  Translational Capability: Strong ability to connect research excellence with practical diagnostic innovation and real-world deployment potential.


Prexilon Private Limited

Corrazone, CUSAT PO, Kochi – 682022, Kerala, India

Copyright © 2026 Prexilon - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept